Literature DB >> 6834109

Nicotine stimulates secretion of both catecholamines and acetylcholinesterase from cultured adrenal chromaffin cells.

F Mizobe, B G Livett.   

Abstract

There is conflicting evidence from studies on sympathetic ganglia and the adrenal medulla concerning the morphological and biochemical localization and physiological role(s) of the enzyme acetylcholinesterase (AChE). Furthermore, the origin of the AChE released from the adrenal medulla (whether from chromaffin cells or splanchnic nerve, or both) has not been firmly established. We have examined the efficacy of cholinergic agonists to release endogenous AChE and catecholamines (CA) from monolayer cultures of purified bovine adrenal chromaffin cells. The nicotinic agonist (nicotine), but not the muscarinic agonist (methacholine), released both AChE and CA from the adrenal chromaffin cells. The concomitant release of CA and AChE evoked by nicotine was Ca++ dependent with a correlation coefficient r = 0.82 (p less than 0.001). The results show that adrenal chromaffin cells in vitro, a system free of splanchnic nerve elements, can still release AChE. The finding that concomitant release of AChE and catecholamines occurs on exposure of the cells to nicotinic agonists suggests that released AChE may have a physiological role at neuroeffector junctions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6834109      PMCID: PMC6564445     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  8 in total

1.  Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.

Authors:  P D Deeble; D J Murphy; S J Parsons; M E Cox
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

2.  Prenatal nicotine exposure increases apnoea and reduces nicotinic potentiation of hypoglossal inspiratory output in mice.

Authors:  Dean M Robinson; Karen C Peebles; Henry Kwok; Brandon M Adams; Lan-Ling Clarke; Gerald A Woollard; Gregory D Funk
Journal:  J Physiol       Date:  2002-02-01       Impact factor: 5.182

3.  Use of a novel radiometric method to assess the inhibitory effect of donepezil on acetylcholinesterase activity in minimally diluted tissue samples.

Authors:  Tatsuya Kikuchi; Toshimitsu Okamura; Takuya Arai; Takayuki Obata; Kiyoshi Fukushi; Toshiaki Irie; Tetsuya Shiraishi
Journal:  Br J Pharmacol       Date:  2010-04       Impact factor: 8.739

Review 4.  Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.

Authors:  Graeme Eisenhofer; Graham Rivers; Alejandro L Rosas; Zena Quezado; William M Manger; Karel Pacak
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

5.  Muscarinic receptor modulation of release of [Met5]enkephalin immunoreactive material and catecholamines from the bovine adrenal gland.

Authors:  B A Barron; T D Hexum
Journal:  Br J Pharmacol       Date:  1986-12       Impact factor: 8.739

6.  Expression of α3β2β4 nicotinic acetylcholine receptors by rat adrenal chromaffin cells determined using novel conopeptide antagonists.

Authors:  Arik J Hone; Lola Rueda-Ruzafa; Thomas J Gordon; Joanna Gajewiak; Sean Christensen; Tino Dyhring; Almudena Albillos; J Michael McIntosh
Journal:  J Neurochem       Date:  2020-02-11       Impact factor: 5.372

7.  Gintonin facilitates catecholamine secretion from the perfused adrenal medulla.

Authors:  Seung-Yeol Na; Ki-Hwan Kim; Mi-Sung Choi; Kang-Su Ha; Dong-Yoon Lim
Journal:  Korean J Physiol Pharmacol       Date:  2016-10-28       Impact factor: 2.016

Review 8.  Regulation of the differentiation of PC12 pheochromocytoma cells.

Authors:  K Fujita; P Lazarovici; G Guroff
Journal:  Environ Health Perspect       Date:  1989-03       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.